Based on the analysis of immune infiltration, we infer that the high-expression group of NUDT1 is related to the decreased infiltration of monocytes and M1 macrophages, which leads to adverse outcomes in ccRCC patients. This evidence concerns the gene NUDT1 and nonpapillary renal cell carcinoma.